Text full multimedia monochrome

First time here?

Find out more about how The Lecture List works.

Coronavirus situation update

Our lecture organisers may or may not have had time to update their events with cancellation notices. Clearly social gatherings are to be avoided and that includes lectures. STAY AT HOME FOLKS, PLEASE.


Find out what you can do to keep The Lecture List online

DNA repair: protecting the blueprint for life

GlaxoSmithKline Prize Lecture (open to the public)

Our DNA, the ‘stuff of life’, is a fragile molecule that is continually under assault from agents in the environment, our diet, and even from normal processes that take place within the cell. It is therefore critically important that damage to our genetic material is recognised and efficiently removed or repaired. If not, the consequences can be disastrous, leading to cancers and other diseases. All organisms therefore devote a significant portion of their genome towards the protection and maintenance of DNA integrity.
Dr Stephen West will discuss recent advances in our understanding of DNA repair, with particular emphasis on processes that promote the rejoining of DNA strand breaks.

Dr Stephen West FRS is a Senior Group Leader at the London Research Institute of Cancer Research UK. He was awarded the 2010 Royal Society GlaxoSmithKline Prize and Lecture for his pioneering work on the molecular mechanisms of genetic recombination and DNA repair and their relation to tumorigenesis.

Doors will open at 5.45pm and seats will be allocated on a first-come-first-served basis.


Dr Stepehn West FRS | talks | www


Date and Time:

1 December 2010 at 6:30 pm


1 hour



The Royal Society
6-9 Carlton House Terrace
+44 20 74 51 2500

More at The Royal Society...




Available from:

Additional Information:

Admission free – no ticket or advance booking required.

Register to tell a friend about this lecture.


If you would like to comment about this lecture, please register here.


Any ad revenue is entirely reinvested into the Lecture List's operating fund